The reconstitution decision you make at the beginning of your protocol determines whether you will need to split doses later
Since then, several clinical studies have shown its safe and effective use - but the pharmacuetical companies have decided not to (yet) pursue FDA-Approval (likely because each new FDA-Approval costs several million dollars to go through the process, and because there are a good deal of drugs used off-label in the way tranexamic acid is for melasma, especially when the drug has a long history of safety and efficacy, as is in this case)
While 5-Amino-1MQ shows promise, our team has found that studies incorporating controlled diet and regular physical activity often yield the most pronounced and meaningful 5-Amino-1MQ before and after results
Neurology, 86(16 Supplement), P3-154
For a summary of the published research, Rupa Healths clinical review of BPC-157 covers the available data
at this concentration, 0.1 mL drawn into an insulin syringe corresponds to 500 g of peptide